Adult Stem Cells Might Help Some Patients with Alzheimer Disease, Reports Journal of American Physicians and Surgeons
March 25, 2019 11:48 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., March 25, 2019 (GLOBE NEWSWIRE) -- Promising results in animal models of neurodegenerative diseases suggest that a patient’s own stem cells, derived from his fat tissue or bone...
Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions
October 27, 2015 21:07 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced that the United States Patent and Trademark Office (USPTO) has granted a...
Mesoblast Chairman's Address to 2015 Annual General Meeting
October 22, 2015 02:00 ET | Mesoblast
NEW YORK, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Thank you for attending the Mesoblast 2015 Annual General Meeting. This has been another exciting and productive year in the history of our...
Diabetic Nephropathy Trial Results Selected For Late-Breaking Presentation At American Diabetes Association Annual Meeting
May 18, 2015 05:39 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, May 18, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; USOTC: MBLTY) today announced that Phase 2 trial results of its lead product candidate for the treatment...
Mesoblast Partner JCR Pharmaceuticals Files for Marketing Approval of the First Allogeneic Stem Cell Product in Japan
September 30, 2014 20:17 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported that its Japanese partner, JCR...
Mesoblast Unveils Path to Bring Its Key Products to Market
August 25, 2014 20:27 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 25, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported 2014 financial results and unveiled its...
National Institutes of Health and Mesoblast Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure
August 06, 2014 20:57 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced the signing of an agreement with the United...
Boardroom Radio Interview with Mesoblast Chief Executive
February 02, 2014 20:06 ET | Mesoblast
NEW YORK, Feb. 2, 2014 (GLOBE NEWSWIRE) -- Audio link - http://www.brrmedia.com/event/120127BRR    Today at Boardroom Radio (BRR) we're once again joined by Mr Silviu Itescu, who is...
MESOBLAST ACQUIRES OSIRIS' CULTURE EXPANDED STEM CELL THERAPEUTIC BUSINESS
October 10, 2013 20:28 ET | Mesoblast
MELBOURNE, Australia and NEW YORK, Oct. 10, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced the acquisition of the entire...
Mesoblast's Strong Cash Position Enables Execution of Late-Stage Clinical Trials
August 29, 2013 00:42 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 29, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company, Mesoblast Limited (ASX:MSB) (OTC ADR:MBLTY), today provided its full year financial results. The...